Results 161 to 170 of about 726,956 (307)

Characterizing the salivary RNA landscape to identify potential diagnostic, prognostic, and follow‐up biomarkers for breast cancer

Molecular Oncology, EarlyView.
This study explores salivary RNA for breast cancer (BC) diagnosis, prognosis, and follow‐up. High‐throughput RNA sequencing identified distinct salivary RNA signatures, including novel transcripts, that differentiate BC from healthy controls, characterize histological and molecular subtypes, and indicate lymph node involvement.
Nicholas Rajan, Irina Primac, Emre Etlioglu, Laurens Debruyne, Ann Janssen, Magy Sallam, Kevin Tabury, Roel Quintens, Wiebren Tjalma, Mohammed Abderrafi Benotmane   +9 more
wiley   +1 more source

Choosing appropriate patient‐reported outcome measures for prostate disease

BJUI Compass, 2022
Alexander Ng, Pramit Khetrapal, Chris Brew‐Graves, Nicola Muirhead, Aqua Asif, Vinson Wai‐Shun Chan, Arjun Nathan, Veeru Kasivisvanathan   +7 more
doaj   +1 more source

Measuring pediatric patient-reported outcomes: good progress but a long way to go [PDF]

, 2013
I‐Chan Huang, Dennis A. Revicki, Carolyn E. Schwartz   +2 more
openalex   +1 more source

Bridging the gap: Multi‐stakeholder perspectives of molecular diagnostics in oncology

Molecular Oncology, EarlyView.
Although molecular diagnostics is transforming cancer care, implementing novel technologies remains challenging. This study identifies unmet needs and technology requirements through a two‐step stakeholder involvement. Liquid biopsies for monitoring applications and predictive biomarker testing emerge as key unmet needs. Technology requirements vary by
Jorine Arnouts, Senada Koljenović, Elise Daems, Karolien De Wael, Marc Peeters, Léon C. van Kempen, Greetje Vanhoutte, Karen Zwaenepoel, Timon Vandamme   +8 more
wiley   +1 more source

Clinical events and patient-reported outcome measures in peritoneal dialysis. [PDF]

BMC Nephrol
Malaweera A, Huang LL, McMahon LP.
europepmc   +1 more source

The Genetic Counseling Outcome Scale: a new patient-reported outcome measure for clinical genetics services

, 2011
Marion McAllister, Alex M. Wood, Graham Dunn, Shoshana Shiloh, Chris Todd   +4 more
openalex   +2 more sources

Adenosine‐to‐inosine editing of miR‐200b‐3p is associated with the progression of high‐grade serous ovarian cancer

Molecular Oncology, EarlyView.
A‐to‐I editing of miRNAs, particularly miR‐200b‐3p, contributes to HGSOC progression by enhancing cancer cell proliferation, migration and 3D growth. The edited form is linked to poorer patient survival and the identification of novel molecular targets.
Magdalena Niemira, Anna Skwarska, Karolina Chwialkowska, Agnieszka Ostrowska, Gabriela Sokolowska, Anna Zeller, Anna Erol, Andrzej Eljaszewicz, Bartosz Hanczaruk, Anna Michalska‐Falkowska, Agnieszka Tarasik, Joanna Reszec‐Gielazyn, Pawel Knapp, Marcin Moniuszko, Adam Kretowski   +14 more
wiley   +1 more source

Prevalence of Pain and Analgesic Use in Men With Metastatic Prostate Cancer Using a Patient-Reported Outcome Measure [PDF]

, 2013
Karen A. Autio, Antonia V. Bennett, Xiaoyu Jia, M. Fruscione, Tomasz M. Beer, Daniel J. George, Michael A. Carducci, Christopher J. Logothetis, Robert C. Kane, Laura Sit, Lauren J. Rogak, Michael J. Morris, Howard I. Scher, Ethan Basch   +13 more
openalex   +1 more source

Patient Reported Outcome Measurements

Journal of Pharmaceutical Research, 2015
openaire   +2 more sources

Investigating the cell of origin and novel molecular targets in Merkel cell carcinoma: a historic misnomer

Molecular Oncology, EarlyView.
This study indicates that Merkel cell carcinoma (MCC) does not originate from Merkel cells, and identifies gene, protein & cellular expression of immune‐linked and neuroendocrine markers in primary and metastatic Merkel cell carcinoma (MCC) tumor samples, linked to Merkel cell polyomavirus (MCPyV) status, with enrichment of B‐cell and other immune cell
Richie Jeremian, Sriraam Sivachandran, Melissa Galati, Brandon Ramchatesingh, Hibo Rijal, Johnny Hanna, Elena Netchiporouk, May Chergui, Margaret Redpath, Samy Abou Setah, Ivan V. Litvinov   +10 more
wiley   +1 more source